Ulrich Germing

22.3k total citations · 3 hit papers
252 papers, 7.0k citations indexed

About

Ulrich Germing is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Ulrich Germing has authored 252 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 206 papers in Hematology, 105 papers in Genetics and 41 papers in Molecular Biology. Recurrent topics in Ulrich Germing's work include Acute Myeloid Leukemia Research (192 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (68 papers) and Hematopoietic Stem Cell Transplantation (38 papers). Ulrich Germing is often cited by papers focused on Acute Myeloid Leukemia Research (192 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (68 papers) and Hematopoietic Stem Cell Transplantation (38 papers). Ulrich Germing collaborates with scholars based in Germany, United States and Austria. Ulrich Germing's co-authors include Carlo Aul, Aristoteles Giagounidis, Norbert Gattermann, Rainer Haas, Andrea Kündgen, Norbert Gattermann, Corinna Strupp, Guido Kobbe, Barbara Hildebrandt and Michael Lübbert and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Ulrich Germing

229 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

2009 698 citations Pierre Fenaux, Ghulam J. Mufti et al. Journal of Clinical Oncology profile →
IDH1andIDH2Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia WithNPM1Mutation WithoutFLT3Internal Tandem Duplication

2010 578 citations Katharina S. Götze, Ulrich Germing et al. Journal of Clinical Oncology profile →
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

2007 540 citations Detlef Haase, Ulrich Germing et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulrich Germing Germany	37	5.4k	2.4k	2.4k	971	824	252	7.0k
Rami S. Komrokji United States	45	5.5k 1.0×	2.6k 1.1×	3.1k 1.3×	788 0.8×	934 1.1×	584	7.5k
Adriano Venditti Italy	40	3.6k 0.7×	2.1k 0.9×	1.4k 0.6×	1.2k 1.3×	695 0.8×	259	5.6k
Ghulam Mufti United Kingdom	27	4.7k 0.9×	1.2k 0.5×	2.0k 0.8×	790 0.8×	886 1.1×	101	5.8k
Aristoteles Giagounidis Germany	49	8.5k 1.6×	3.4k 1.4×	3.7k 1.6×	1.5k 1.5×	692 0.8×	259	10.3k
Lionel Adès France	41	4.0k 0.8×	2.1k 0.9×	1.5k 0.6×	637 0.7×	546 0.7×	219	5.6k
Peter L. Greenberg United States	45	9.1k 1.7×	3.2k 1.3×	3.8k 1.6×	1.4k 1.5×	1.0k 1.3×	203	11.0k
Joseph O. Moore United States	42	3.3k 0.6×	1.8k 0.7×	1.5k 0.6×	1.2k 1.2×	962 1.2×	148	6.6k
Nicolas Boissel France	42	3.6k 0.7×	2.0k 0.8×	1.2k 0.5×	1.9k 2.0×	1000 1.2×	200	6.1k
F Bauters France	45	5.2k 1.0×	2.6k 1.1×	3.0k 1.3×	721 0.7×	571 0.7×	211	7.3k
Jamie Cavenagh United Kingdom	40	4.6k 0.9×	2.5k 1.1×	1.1k 0.5×	534 0.5×	1.8k 2.2×	141	6.7k

Countries citing papers authored by Ulrich Germing

Since Specialization

Citations

This map shows the geographic impact of Ulrich Germing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Germing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Germing more than expected).

Fields of papers citing papers by Ulrich Germing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrich Germing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Germing. The network helps show where Ulrich Germing may publish in the future.

Co-authorship network of co-authors of Ulrich Germing

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich Germing. A scholar is included among the top collaborators of Ulrich Germing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich Germing. Ulrich Germing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kündgen, Andrea, Kathrin Nachtkamp, Paul Jäger, et al.. (2025). Outcomes in patients with acute myeloid leukemia older than 70 years within the last 30 years, a single center experience. Annals of Hematology. 104(1). 231–239.

Ganster, Christina, Katayoon Shirneshan, Elżbieta Brzuszkiewicz, et al.. (2024). Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real‐world cohort of patients with lower‐risk MDS. HemaSphere. 8(9). e70014–e70014. 1 indexed citations

Yücel, Aylin, RK Goyal, Rohan Parikh, et al.. (2024). Treatment characteristics and outcomes in lower-risk, non-del(5q) myelodysplastic syndromes: findings from a medical record review in the USA, Canada and Europe. Future Oncology. 20(27). 1993–2004.

Jäger, Paul, Johanna Tischer, Alessia Fraccaroli, et al.. (2024). Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies. Cancers. 16(3). 532–532. 6 indexed citations

Nachtkamp, Kathrin, et al.. (2022). Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS). Cancers. 14(8). 1941–1941. 10 indexed citations

Hildebrandt, Barbara, Guido Kobbe, Norbert Gattermann, et al.. (2022). Therapy-related myeloid neoplasms following treatment for multiple myeloma—a single center analysis. Annals of Hematology. 101(5). 1031–1038. 1 indexed citations

Rautenberg, Christina, Michael Lauseker, Jennifer Kaivers, et al.. (2021). Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1‐mRNA expression in patients with AML and MDS. European Journal Of Haematology. 107(2). 283–292. 15 indexed citations

Germing, Ulrich, Thomas Schroeder, Jennifer Kaivers, et al.. (2019). Novel therapies in low- and high-risk myelodysplastic syndrome. Expert Review of Hematology. 12(10). 893–908. 14 indexed citations

Itzykson, Raphaël, Pierre Fenaux, David Bowen, et al.. (2018). Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults. HemaSphere. 2(6). e150–e150. 65 indexed citations

10.

Neukirchen, Judith, Kathrin Nachtkamp, Carlo Aul, et al.. (2015). Change of prognosis of patients with myelodysplastic syndromes during the last 30 years. Leukemia Research. 39(7). 679–683. 11 indexed citations

11.

Pleyer, Lisa, Ulrich Germing, Wolfgang R. Sperr, et al.. (2014). Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival. Leukemia Research. 38(4). 475–483. 44 indexed citations

12.

Eber, Stefan, Ulrich Germing, H. Heimpel, et al.. (2013). Prävention von Infektionen und Thrombosen nach Splenektomie oder funktioneller Asplenie. Kinder- und Jugendmedizin. 13(3). 197–205. 2 indexed citations

13.

Fenaux, Pierre, Ghulam J. Mufti, Eva Hellström‐Lindberg, et al.. (2009). Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia. Journal of Clinical Oncology. 28(4). 562–569. 698 indexed citations breakdown →

14.

Aul, C., Ulrich Germing, Norbert Gattermann, D. Söhngen, & A. Heyll. (2008). Prognostische Bedeutung der Serum-Thymidinkinase beim myelodysplastischen Syndrom. DMW - Deutsche Medizinische Wochenschrift. 121(37). 1113–1118. 1 indexed citations

15.

Strupp, Corinna, Ulrich Germing, Manuel Aivado, et al.. (2005). The ratio between CD4 + and CD8 + cells in the peripheral blood of patients with hematological malignancies is not altered by thalidomide. Leukemia & lymphoma. 46(7). 999–1006. 4 indexed citations

16.

Rosado, Maria Manuela, Holger Weber, Ulrich Germing, et al.. (2003). Human Immunoglobulin M Memory B Cells Controlling Streptococcus pneumoniae Infections Are Generated in the Spleen. The Journal of Experimental Medicine. 197(7). 939–945. 481 indexed citations

17.

Aul, C., Aristoteles Giagounidis, Ulrich Germing, & Arnold Ganser. (2002). Evaluating the prognosis of patients with myelodysplastic syndromes. Annals of Hematology. 81(9). 485–497. 26 indexed citations

18.

Aul, Carlo, Aristoteles Giagounidis, & Ulrich Germing. (2001). Epidemiological Features of Myelodysplastic Syndromes: Results From Regional Cancer Surveys and Hospital-Based Statistics. International Journal of Hematology. 73(4). 405–410. 62 indexed citations

19.

Heyll, A., Ulrich Germing, A. Wehmeier, et al.. (1998). Dyshematopoiesis in De Novo Acute Myeloid Leukemia: Cell Biological Features and Prognostic Significance. Leukemia & lymphoma. 29(5-6). 523–531. 5 indexed citations

20.

Motherby, Helma, Ulrich Germing, A. Heyll, et al.. (1998). Pleural carcinosis confirmed by adjuvant cytological methods: A case report. Diagnostic Cytopathology. 19(5). 370–374. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact